J. Silvio Gutkind Receives the 2017 IADR Distinguished Scientist Award in Research in Oral Biology
FOR IMMEDIATE RELEASE
IADR contact: Ingrid L. Thomas
+1.703.299.8084 or email@example.com
March 23, 2017
Alexandria, Va., USA - The International Association for Dental Research (IADR) presented J. Silvio Gutkind with the IADR Distinguished Scientist Award in Research in Oral Biology. He was recognized at the Opening Ceremonies of the 95th General Session & Exhibition of the IADR, Wednesday, March 22, 2017, in San Francisco, Calif., USA. This meeting is being held in conjunction with the 46th Annual Meeting of the American Association for Dental Research and the 41st Annual Meeting of the Canadian Association for Dental Research.
Gutkind is a professor in the Department of Pharmacology, University of California San Diego Moores Cancer Center, USA. He has an M.Sc. in pharmacy, M.Sc. in biochemistry and Ph.D. in pharmacy and biochemistry from the University of Buenos Aires, Argentina. From 1992 -2015 he served the National Institutes of Health - National Institute of Dental and Craniofacial Research, Bethesda, Md., USA, in various capacities, including chief of cell growth, Regulation Section and Molecular Carcinogenesis Unit, Oral and Pharyngeal Cancer Branch where he led a national and international effort addressing oral and head and neck malignancies.
Gutkind has recently led a multi-institutional effort aimed at exploring the biochemical consequences and clinical benefits of treating newly diagnosed head and neck cancer patients with mTOR inhibitors. As part of a multidisciplinary team at Moores Cancer Center, he is now investigating the effectiveness and mechanism of action of PI3K/mTOR inhibitors for oral cancer prevention and treatment, both as single agents and as part of novel co-targeting strategies, and he is co-leading with Scott M. Lippman, director, Moores Cancer Center, a new precision prevention medicine trial in oral premalignancy.
As a renowned researcher, Gutkind has been invited to give keynote lectures in the U.S. and abroad, and has been the recipient of numerous awards for his research work, including the Research & Hope Award for Excellence in Academic Research presented by Pharmaceutical Research and Manufacturers of America, the Elliot Osserman Award presented by the Israel Cancer Research Foundation and the National Institutes of Health Director's Award.
Sponsored by Church & Dwight Company, the Research in Oral Biology Award is one of the 17 IADR Distinguished Scientist Awards and is one of the highest honors bestowed by IADR. The award consists of a monetary prize and plaque and recognizes outstanding research in the field of oral biology.
About the International and American Associations for Dental Research The International Association for Dental Research (IADR) is a nonprofit organization with nearly 11,000 individual members worldwide, dedicated to: (1) advancing research and increasing knowledge for the improvement of oral health worldwide, (2) supporting and representing the oral health research community, and (3) facilitating the communication and application of research findings. To learn more, visit www.iadr.org.